Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome
Open Access
- 24 February 2009
- journal article
- Published by H1 Connect in F1000 Medicine Reports
- Vol. 1 (11)
- https://doi.org/10.3410/m1-11
Abstract
Hematopoietic stem cell transplantation in patients with myelodysplastic syndromeThis publication has 26 references indexed in Scilit:
- Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1–risk myelodysplastic syndromes with karyotypes other than deletion 5qBlood, 2008
- Myelodysplastic syndromesCancer, 2007
- Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q DeletionThe New England Journal of Medicine, 2006
- Efficacy of Lenalidomide in Myelodysplastic SyndromesThe New England Journal of Medicine, 2005
- Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group BJournal of Clinical Oncology, 2002
- Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidineBritish Journal of Haematology, 2001
- MyelodysplasiaThe New England Journal of Medicine, 1999
- International Scoring System for Evaluating Prognosis in Myelodysplastic SyndromesBlood, 1997
- Establishing the incidence of myelodysplastic syndromeBritish Journal of Haematology, 1994
- Proposals for the classification of the myelodysplastic syndromes.1982